We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Optimized Gold Nanoparticles to Improve Drug Delivery, Cancer Therapy and Imaging

By HospiMedica International staff writers
Posted on 04 Jun 2025

Health care professionals utilize gold nanoparticles for a variety of medical purposes, including diagnostic imaging and cancer treatment. More...

Gold is an ideal material for these applications due to its biocompatibility, stability, and visibility in imaging tests. However, despite the wide use of gold nanoparticles in medicine, there is limited understanding of how their size influences their performance. L-cysteine, an amino acid crucial in many biological functions, can prevent gold nanoparticles from aggregating, which is essential for ensuring the success of medical treatments. By forming a strong bond with gold, L-cysteine facilitates the attachment of nanoparticles to specific targets, such as cancer cells. A new study aimed at exploring the relationship between the size of gold nanoparticles and their interaction with L-cysteine found that smaller nanoparticles tend to exhibit the best performance.

Researchers at Western University (London, ON, Canada) collaborated with the Canadian Light Source at the University of Saskatchewan (Saskatoon, SK, Canada) to investigate how the size of gold nanoparticles affects their interaction with L-cysteine. Using synchrotron light along with other advanced techniques, the team found that smaller gold nanoparticles (5 nanometers) formed stronger bonds with L-cysteine compared to larger nanoparticles (10, 15, and 20 nanometers). For context, a human hair is approximately 100,000 nanometers wide.

The findings, published in the journal Particle & Particle Systems Characterization, also revealed that the smallest gold nanoparticles were less likely to clump together when L-cysteine was present. Clumping can impair the effectiveness, stability, and safety of nanoparticles. The researchers believe that these insights could help optimize the size of gold nanoparticles, thereby enhancing drug delivery, improving cancer treatment, and refining imaging techniques.

“It is important to know if the (gold) particle stays the same size, because each size has specific properties and you design the particle in this way, and then don't want it to change in the human body,” said Yolanda Hedberg, a professor of chemistry at Western University. “When we understand exactly how the size is affecting the reaction with the environment, we can design the particle size in a way that we make the nanomedicine as effective as possible.”


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Digital Radiography System (Ceiling Free)
Digix CF Series
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.